Efferocytosis of vascular cells in cardiovascular disease
- PMID: 34171333
- PMCID: PMC8695637
- DOI: 10.1016/j.pharmthera.2021.107919
Efferocytosis of vascular cells in cardiovascular disease
Abstract
Cell death and the clearance of apoptotic cells are tightly regulated by various signaling molecules in order to maintain physiological tissue function and homeostasis. The phagocytic removal of apoptotic cells is known as the process of efferocytosis, and abnormal efferocytosis is linked to various health complications and diseases, such as cardiovascular disease, inflammatory diseases, and autoimmune diseases. During efferocytosis, phagocytic cells and/or apoptotic cells release signals, such as "find me" and "eat me" signals, to stimulate the phagocytic engulfment of apoptotic cells. Primary phagocytic cells are macrophages and dendritic cells; however, more recently, other neighboring cell types have also been shown to exhibit phagocytic character, including endothelial cells and fibroblasts, although they are comparatively slower in clearing dead cells. In this review, we focus on macrophage efferocytosis of vascular cells, such as endothelial cells, smooth muscle cells, fibroblasts, and pericytes, and its relation to the progression and development of cardiovascular disease. We also highlight the role of efferocytosis-related molecules and their contribution to the maintenance of vascular homeostasis.
Keywords: cardiovascular complications; endothelial cell; engulfment of apoptotic cells; macrophage; phagocytosis; smooth muscle cell.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that there are no competing interests.
Similar articles
-
Efferocytosis: the resolution of inflammation in cardiovascular and cerebrovascular disease.Front Immunol. 2024 Nov 26;15:1485222. doi: 10.3389/fimmu.2024.1485222. eCollection 2024. Front Immunol. 2024. PMID: 39660125 Free PMC article. Review.
-
Defective efferocytosis of vascular cells in heart disease.Front Cardiovasc Med. 2022 Sep 30;9:1031293. doi: 10.3389/fcvm.2022.1031293. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36247464 Free PMC article. Review.
-
MicroRNAs and Efferocytosis: Implications for Diagnosis and Therapy.Mini Rev Med Chem. 2022;22(20):2641-2660. doi: 10.2174/1389557522666220330150937. Mini Rev Med Chem. 2022. PMID: 35362375 Review.
-
Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms.Pharmacol Ther. 2018 Aug;188:12-25. doi: 10.1016/j.pharmthera.2018.02.003. Epub 2018 Feb 11. Pharmacol Ther. 2018. PMID: 29444453 Review.
-
Contribution of Macrophage Efferocytosis to Liver Homeostasis and Disease.Front Immunol. 2019 Nov 14;10:2670. doi: 10.3389/fimmu.2019.02670. eCollection 2019. Front Immunol. 2019. PMID: 31798592 Free PMC article. Review.
Cited by
-
Transcriptional analysis of efferocytosis in mouse skin wounds.bioRxiv [Preprint]. 2024 Aug 13:2024.08.12.607219. doi: 10.1101/2024.08.12.607219. bioRxiv. 2024. PMID: 39185146 Free PMC article. Preprint.
-
Advances in biological functions and applications of apoptotic vesicles.Cell Commun Signal. 2023 Sep 25;21(1):260. doi: 10.1186/s12964-023-01251-9. Cell Commun Signal. 2023. PMID: 37749626 Free PMC article. Review.
-
Immunomodulation of wound healing leading to efferocytosis.Smart Med. 2024 Jan 31;3(1):e20230036. doi: 10.1002/SMMD.20230036. eCollection 2024 Feb. Smart Med. 2024. PMID: 39188510 Free PMC article. Review.
-
Developmental endothelial locus 1: the present and future of an endogenous factor in vessels.Front Physiol. 2024 Aug 9;15:1347888. doi: 10.3389/fphys.2024.1347888. eCollection 2024. Front Physiol. 2024. PMID: 39206385 Free PMC article. Review.
-
Endothelial dysfunction in the kidney transplant population: Current evidence and management strategies.World J Transplant. 2025 Mar 18;15(1):97458. doi: 10.5500/wjt.v15.i1.97458. World J Transplant. 2025. PMID: 40104196 Free PMC article. Review.
References
-
- Abdel Rahman F, d’Almeida S, Zhang T, Asadi M, Bozoglu T, Bongiovanni D, … Ziegler T (2021). Sphingosine-1-phosphate attenuates lipopolysaccharide-induced pericyte loss via activation of Rho-A and MRTF-A. Thrombosis and Haemostasis 121, 341–350. - PubMed
-
- Abraham MC, & Shaham S (2004). Death without caspases, caspases without death. Trends in Cell Biology 14, 184–193. - PubMed
-
- Arur S, Uche UE, Rezaul K, Fong M, Scranton V, Cowan AE, … Han DK (2003). Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Developmental Cell 4, 587–598. - PubMed
-
- Avanzi GC, Gallicchio M, Bottarel F, Gammaitoni L, Cavalloni G, Buonfiglio D, … Dianzani C (1998). Gas6 inhibits granulocyte adhesion to endothelial cells. Blood 91, 2334–2340. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources